Homeopathic Treatments On Fringe Of Mainstream Medicine To Be Targeted By FDA
Officials have announced that the Food and Drug Administration is going to be cracking down on these treatments that many scientists view as modern-day snake oil. The agency plans to focus on the ones that carry the biggest safety risks, including those marketed for children or for serious diseases.
The Associated Press:
US Health Officials To Target High-Risk Alternative Remedies
U.S. health officials plan to crack down on a growing number of unproven alternative remedies, focusing on products containing dangerous ingredients that have occasionally been linked to serious injury and death. The Food and Drug Administration on Monday issued a new proposal for regulating homeopathic medicines that have long been on the fringe of mainstream medicine. The agency plans to target products that pose the biggest safety risks, including those marketed for children or for serious diseases. (12/18)
The Washington Post:
FDA Takes More Aggressive Stance Toward Homeopathic Drugs
Homeopathy is based on an 18th-century idea that substances that cause disease symptoms can, in very small doses, cure the same symptoms. Modern medicine, backed up by numerous studies, has disproved the central tenets of homeopathy and shown that the products are worthless at best and harmful at worst. Under U.S. law, homeopathic drugs are required to meet the same approval rules as other drugs. But under a policy adopted in 1988, the agency has used “enforcement discretion” to allow the items to be manufactured and distributed without FDA approval. Agency officials don't plan to begin requiring that homeopathic products get approval — officials say that would be impractical — but they are signaling stepped-up scrutiny for items deemed a possible health threat. (McGinley, 12/18)
NPR:
FDA Unveils Policy To Target Risky Homeopathic Treatments
"In recent years, we've seen a large uptick in products labeled as homeopathic that are being marketed for a wide array of diseases and conditions, from the common cold to cancer," FDA Commissioner Scott Gottlieb said in a statement announcing the new policy. "In many cases, people may be placing their trust and money in therapies that may bring little to no benefit in combating serious ailments, or worse — that may cause significant and even irreparable harm because the products are poorly manufactured, or contain active ingredients that aren't adequately tested or disclosed to patients," Gottlieb says. (Stein, 12/18)
In other public health news from the administration —
Los Angeles Times:
EPA Says Herbicide In Roundup Weed Killer Doesn't Cause Cancer, Contradicting California Regulators
The federal Environmental Protection Agency on Monday said glyphosate, the primary ingredient in the weed killer Roundup and one of the most widely used herbicides in agriculture, likely does not cause cancer. The assessment contradicts the conclusion of a European scientific panel as well as California regulators, who have included the chemical on the Proposition 65 list of probable carcinogens. (Mohan, 12/18)
